GeneDx Holdings Corp.WGSNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR+90.0%
5Y CAGR-21.2%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+90.0%/yr
Annual compound
5Y CAGR
-21.2%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202541.99%
2024-13.47%
2023-42.43%
20226.12%
202194.43%
2020138.14%
20190.00%